Development and feasibility of a rapid point-of-care Silicon Nanosystem for the Prediction of Drug Response (SNP-DR)
Lead Participant:
DNAE GROUP HOLDINGS LIMITED
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| DNAE GROUP HOLDINGS LIMITED | £789,362 | £ 286,010 |
Participant |
||
| IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE | £271,036 | £ 271,035 |
| PFIZER LIMITED | £122,381 | £ 44,342 |
People |
ORCID iD |